Background: The use of HPV-mRNA test in the follow-up after LEEP is still matter of debate, with regard to its capacity of prediction relapse. Objective: The aim of the present study is to evaluate the reliability of HPV-mRNA test to predict the residual and recurrent disease, and its accuracy in the follow-up of patients treated for CIN 2/3. Study design: Multicenter prospective cohort study. Patients who underwent LEEP after a biopsy diagnosing CIN 2/3 were followed at 3, 6, 12, 24 and 36 months. Each check up included cytology, colposcopy, HPV-DNA test (LiPA) and HPV-mRNA test (PreTect HPV Proofer Kit NorChip). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), of HPV-DNA test and HPV-mRNA test to predict relapse, recurrent and residual disease. Using multiple logistic regression, the statistical significant variables as assessed in univariate analysis were entered and investigated as predictors of relapse disease. Results: The mRNA-test in predicting a residual disease had a sensitivity of 52% and a NPV of 91%, whereas DNA-test had 100% and 100%, respectively. On the contrary in the prediction of recurrent disease mRNA-test had a sensitivity and a NPV of 73.5% and 97%, whereas DNA-test had 44% and 93%. On the multivariate analysis, age, cytology, HPV DNA and mRNA test achieved the role of independent predictors of relapse. Conclusion: HPV-mRNA test has a higher sensitivity and a higher NPV in predicting recurrent disease, for this reason it should be used in the follow-up of patients treated with LEEP for CIN 2/3 in order to individualize the timing of check up. © 2014 Elsevier B.V.
Frega, A., Sesti, F., Lombardi, D., Votano, S., Sopracordevole, F., Catalano, A., et al. (2014). Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3. JOURNAL OF CLINICAL VIROLOGY, 60(1), 39-43.
|Tipologia:||Articolo su rivista|
|Citazione:||Frega, A., Sesti, F., Lombardi, D., Votano, S., Sopracordevole, F., Catalano, A., et al. (2014). Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3. JOURNAL OF CLINICAL VIROLOGY, 60(1), 39-43.|
|Settore Scientifico Disciplinare:||Settore MED/40 - Ginecologia e Ostetricia|
|Revisione (peer review):||Esperti anonimi|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.jcv.2014.01.017|
|Stato di pubblicazione:||Pubblicato|
|Data di pubblicazione:||2014|
|Titolo:||Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3|
|Autori:||Frega, A; Sesti, F; Lombardi, D; Votano, S; Sopracordevole, F; Catalano, A; Milazzo, Gn; Lombardo, R; Assorgi, C; Olivola, S; Chiusuri, V; Ricciardi, E; French, D; Moscarini, M|
|Appare nelle tipologie:||01 - Articolo su rivista|